Description

GABASIGN 800 CAP is a high-dose formulation of Gabapentin 800 mg, indicated for the treatment of partial seizures, diabetic neuropathy, postherpetic neuralgia, and chronic nerve-related pain syndromes. Gabapentin is a well-established anticonvulsant and neuropathic pain reliever that modulates calcium channels in the central nervous system, helping to reduce abnormal nerve activity and pain transmission.

This 800 mg strength is typically prescribed for patients requiring maximum therapeutic response, especially those who have not responded adequately to lower strengths such as 300, 400, or 600 mg. The dosage should be increased gradually under medical supervision to minimize side effects and optimize efficacy.

Therapeutic Applications:

• Adjunctive therapy for partial-onset seizures

• Chronic neuropathic pain, including diabetic nerve pain

• Postherpetic neuralgia (pain after shingles)

• Fibromyalgia and spinal cord-related pain

• Restless leg syndrome (off-label use)

Key Benefits:

• Maximum strength for severe nerve pain and seizures

• Long-acting relief from chronic neurological conditions

• Favorable side effect profile compared to traditional painkillers

• Non-addictive with minimal drug interactions

• Export-ready formulation manufactured in WHO-GMP certified facilities

GABASIGN 800 CAP is produced under stringent quality standards and is distributed internationally by BLUEPILL EXPRESS, a global exporter of pharmaceutical products to markets across Asia, Africa, Latin America, the Middle East, and Europe. Export documentation, COAs, and private labeling support are available.